MwanzoMRK • NYSE
add
Merck & Co.
$ 119.30
Baada ya Saa za Kazi:(0.00%)0.00
$ 119.30
Imefungwa: 26 Feb, 18:09:44 GMT -5 · USD · NYSE · Kanusho
Bei iliyotangulia
$ 122.46
Bei za siku
$ 119.00 - $ 122.50
Bei za mwaka
$ 73.31 - $ 125.14
Thamani ya kampuni katika soko
294.96B USD
Wastani wa hisa zilizouzwa
12.81M
Uwiano wa bei na mapato
16.38
Mgao wa faida
2.85%
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 16.40B | 4.97% |
Matumizi ya uendeshaji wa biashara | 6.73B | 2.34% |
Mapato halisi | 2.96B | -20.84% |
Kiwango cha faida halisi | 18.07 | -24.58% |
Mapato kwa kila hisa | 2.04 | 18.60% |
EBITDA | 6.79B | 5.24% |
Asilimia ya kodi ya mapato | 13.39% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 14.56B | 6.40% |
Jumla ya mali | 136.87B | 16.87% |
Jumla ya dhima | 84.20B | 19.04% |
Jumla ya hisa | 52.66B | — |
hisa zilizosalia | 2.48B | — |
Uwiano wa bei na thamani | 5.87 | — |
Faida inayotokana na mali | 10.09% | — |
Faida inayotokana mtaji | 14.31% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (USD) | Des 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 2.96B | -20.84% |
Pesa kutokana na shughuli | 2.86B | -17.19% |
Pesa kutokana na uwekezaji | -11.20B | -675.69% |
Pesa kutokana na ufadhili | 4.75B | 257.89% |
Mabadiliko halisi ya pesa taslimu | -3.57B | -160.58% |
Mtiririko huru wa pesa | 2.31B | -53.39% |
Kuhusu
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fourth on the list of largest biomedical companies by revenue.
The company's revenues are primarily from cancer treatments, vaccines, and animal health products. In 2024, 46% of the company's revenue, or $29.5 billion, came from sales of Keytruda, a PD-1 inhibitor used to treat various types of cancers, and 13% of the company's revenue, or $8.6 billion, came from sales of Gardasil, an HPV vaccine. In addition, 9% of the company's revenue, or $5.8 billion, came from the sales of animal health products.
The company is ranked 65th on the Fortune 500 and 76th on the Forbes Global 2000.
In 1891, Merck & Co. was established as the American affiliate of Merck Group, founded by the Merck family, and the companies are still in trademark disputes in several countries over the right to use the name "Merck". Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1 Jan 1891
Tovuti
Wafanyakazi
74,000
